Events

Mission Soil Living Labs and Soil Literacy: Empowering Communities for Healthy Soils
JUN
Wed
11
09:00 - 15:00

Starts in 3 days from now

Location

online

Programmes
Agro-Food, Environment Missions

The work programme 2025 of the mission "a soil deal for Europe" has recently been published. This event aims at supporting those who interested in applying to the 2025 Mission Soil call topics funding projects establishing Soil Health Living Labs such as land managers, researchers, soil educators, communicators, and NGOs, public authorities (local and regional), agricultural extension services, Living Lab practitioners, representatives from cultural and creative sectors.

You can find all the details here

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.